MedPath
NMPA Approval

Levothyroxine Sodium Tablets

H20160059

MERCK KGAA

September 25, 2019

H20160059

Drug Information

左甲状腺素钠片

优甲乐

片剂

100μg(以左甲状腺素钠计)

化学药品

September 25, 2019

March 20, 2024

Company Information

Applicant Company

MERCK KGAA

37 rue Saint Romain 69379 LYON CEDEX 08 - FRANCE

Manufacturing Company

MERCK KGAA

Frankfurter Straβe 250 64293 Darmstadt Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左甲状腺素钠片 - NMPA 批准文号 | MedPath